Voriconazole (n-1) (2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(lH-1,2,4- triazol-1-yl) butan-2-ol R-(-)-l0-camphor sulphonate - USDMF
Product Description
Maithri Drugs Private Limited
-
IN -
2020On CPHI since
-
4Certificates
-
250 - 499Employees
Company types
Primary activities
Categories
Specifications
Maithri Drugs Private Limited
-
IN
-
2020On CPHI since
-
4Certificates
-
250 - 499Employees
Company types
Primary activities
More Products from Maithri Drugs Private Limited (34)
-
Product Strontium Ranelate - USDMF
Osteoporosis
-
Product Trifarotene
Acne vulgaris
-
Product Varenicline Tartrate - USDMF
Smoking Cessation Agent
-
Product Viloxazine Hydrochloride
Deficit hyperactivity disorder
-
Product Vonoprazan Fumarate
Anti-ulcerative
-
Product Zonisamide - USDMF, EMDF
Anticonvulsant
-
Product Besifloxacin Hydrochloride - USDMF
Antibacterials -
Product Brimonidine Tartrate - USDMF, CEP
Antiglaucoma -
Product Carbidopa - USDMF, CEP
Antiparkinsonian -
Product Carbimazole - CEP, USDMF
Antihyperthyroidism -
Product Chlorthalidone / Chlortalidone - USDMF, CEP, KDMF
Antihypertensive
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance